ARIADNE: A Study of Weight Loss for Diabetes Treatment and Wellbeing

NAActive, not recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

September 1, 2025

Conditions
Type2diabetesDisordered EatingObesityOverweight and ObesityDiet Habit
Interventions
BEHAVIORAL

Low calorie total diet replacement

"Summary~1. Weeks 1-12: TDR phase~2. Weeks 13-14: Food reintroduction phase I~3. Weeks 15-16: Food reintroduction phase II~4. Weeks 17 till 20: Food reintroduction phase III~5. Weeks 21 till 24: Maintenance phase"

OTHER

Usual care

Participants allocated to the control group will be offered and continue benefiting from standard care. Participants will not be stopped from pursuing any behavioural weight management programme but if they do, this will be recorded.

Trial Locations (1)

OX26GG

Nuffield Department of Primary Care Health Sciences, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT05744232 - ARIADNE: A Study of Weight Loss for Diabetes Treatment and Wellbeing | Biotech Hunter | Biotech Hunter